CD40LG and leprosy: They evaluated the levels of anti-PGL-1 IgM antibody as well as IP-10, CCL4 and CRP in blood collected from leprosy patients and observed that combined detection of these biomarkers significantly improved the diagnostic potential, particularly for PB leprosy in all studied regions.